Key Points
- Integer VP Tommy Thomas sold 884 shares on Nov. 11 at an average price of $70.15 for about $62,013, reducing his position by 19.73% to 3,596 shares (valued ≈ $252,259), per an SEC filing.
- Integer topped Q3 estimates with EPS of $1.79 (vs. $1.68) and revenue +8.4% YoY, set FY2025 guidance of $6.29–$6.43 EPS, and its board approved a $200 million buyback (up to ~8.3% of shares).
- Several brokers cut targets and ratings recently (e.g., Piper Sandler trimmed its target to $82), leaving the consensus rating at Hold with an average price target of $96.75.
Integer Holdings Corporation (NYSE:ITGR - Get Free Report) VP Tommy Thomas sold 884 shares of the business's stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total value of $62,012.60. Following the sale, the vice president directly owned 3,596 shares in the company, valued at $252,259.40. This trade represents a 19.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Integer Trading Up 1.8%
NYSE:ITGR traded up $1.22 during mid-day trading on Friday, reaching $69.27. The company's stock had a trading volume of 229,779 shares, compared to its average volume of 605,196. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The stock has a market cap of $2.43 billion, a P/E ratio of 28.90, a P/E/G ratio of 0.60 and a beta of 0.95. The company's fifty day simple moving average is $92.45 and its two-hundred day simple moving average is $107.61. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $146.36.
Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping analysts' consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same quarter in the previous year, the firm earned $1.43 EPS. The business's revenue was up 8.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, equities analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.
Integer announced that its Board of Directors has approved a stock buyback program on Tuesday, November 4th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to buy up to 8.3% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on ITGR. Piper Sandler dropped their target price on Integer from $155.00 to $82.00 and set an "overweight" rating on the stock in a report on Friday, October 24th. Argus lowered Integer from a "buy" rating to a "hold" rating in a research note on Friday, October 24th. Weiss Ratings reissued a "hold (c-)" rating on shares of Integer in a report on Friday, October 31st. Benchmark reissued a "hold" rating on shares of Integer in a research note on Friday, October 24th. Finally, Wells Fargo & Company reissued an "equal weight" rating and set a $80.00 price objective (down previously from $132.00) on shares of Integer in a research report on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $96.75.
Get Our Latest Report on ITGR
Hedge Funds Weigh In On Integer
Hedge funds have recently bought and sold shares of the business. Teacher Retirement System of Texas purchased a new position in Integer during the first quarter valued at approximately $579,000. Xponance Inc. raised its position in shares of Integer by 5.1% in the first quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock worth $297,000 after acquiring an additional 122 shares during the period. Edgestream Partners L.P. increased its holdings in Integer by 208.4% in the 1st quarter. Edgestream Partners L.P. now owns 36,729 shares of the medical equipment provider's stock worth $4,334,000 after acquiring an additional 24,819 shares in the last quarter. Cooke & Bieler LP boosted its stake in Integer by 6.3% during the 1st quarter. Cooke & Bieler LP now owns 317,393 shares of the medical equipment provider's stock worth $37,456,000 after purchasing an additional 18,790 shares during the last quarter. Finally, Guidance Capital Inc. grew its holdings in Integer by 5.8% in the 1st quarter. Guidance Capital Inc. now owns 3,819 shares of the medical equipment provider's stock valued at $480,000 after buying an additional 208 shares in the last quarter. Institutional investors own 99.29% of the company's stock.
About Integer
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
